COVID-19 pathophysiology: A review

[1]  Y. Hu,et al.  [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[2]  H. Cokugras,et al.  SARS-CoV-2 infection in children , 2020, Turk pediatri arsivi.

[3]  A. Vespignani,et al.  Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study , 2020, The Lancet Infectious Diseases.

[4]  R. Moresky,et al.  Centring sexual and reproductive health and justice in the global COVID-19 response , 2020, The Lancet.

[5]  Yan Liu,et al.  Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV , 2020, Nature Communications.

[6]  P. Brodin.  Why is COVID‐19 so mild in children? , 2020, Acta paediatrica.

[7]  Haiyan Qiu,et al.  Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study , 2020, The Lancet Infectious Diseases.

[8]  G. Onder,et al.  Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. , 2020, JAMA.

[9]  C. Eastin,et al.  Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China , 2020, The Journal of Emergency Medicine.

[10]  D. Raoult,et al.  Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial , 2020, International Journal of Antimicrobial Agents.

[11]  Malik Peiris,et al.  Viral dynamics in mild and severe cases of COVID-19 , 2020, The Lancet Infectious Diseases.

[12]  Zhigang Tian,et al.  Functional exhaustion of antiviral lymphocytes in COVID-19 patients , 2020, Cellular & Molecular Immunology.

[13]  Yuan Wei,et al.  A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 , 2020, The New England journal of medicine.

[14]  Xiuyong Li,et al.  Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19 , 2020, Journal of medical virology.

[15]  Edward Livingston,et al.  Coronavirus Disease 2019 (COVID-19) in Italy. , 2020, JAMA.

[16]  Xiaohu Zheng,et al.  Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients , 2020, National science review.

[17]  Jie Hao,et al.  Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection , 2020, Frontiers of Medicine.

[18]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[19]  R. Morgan,et al.  COVID-19: the gendered impacts of the outbreak , 2020, The Lancet.

[20]  Amjad D. Al-Nasser,et al.  SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far , 2020, Pathogens.

[21]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[22]  Zhongyi Jiang,et al.  Epidemiology of COVID-19 Among Children in China , 2020, Pediatrics.

[23]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[24]  Haibo Xu,et al.  Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer , 2020, Journal of Thoracic Oncology.

[25]  Jian-min Jin,et al.  Gender Differences in Patients With COVID-19: Focus on Severity and Mortality , 2020, Frontiers in Public Health.

[26]  Heshui Shi,et al.  Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet Infectious Diseases.

[27]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[28]  Andrea Marzi,et al.  Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses , 2020, Nature Microbiology.

[29]  Young-Jun Park,et al.  Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.

[30]  Jiyuan Zhang,et al.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.

[31]  Chuan Qin,et al.  Dysregulation of immune response in patients with COVID-19 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  Z. Zhao,et al.  Structure analysis of the receptor binding of 2019-nCoV , 2020, Biochemical and Biophysical Research Communications.

[33]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[34]  Jing Zhao,et al.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.

[35]  Pablo R. Murcia,et al.  Virus–virus interactions impact the population dynamics of influenza and the common cold , 2019, Proceedings of the National Academy of Sciences.

[36]  Shaohua Chen,et al.  Age related human T cell subset evolution and senescence , 2019, Immunity & Ageing.

[37]  M. Shimaoka,et al.  The Use of Volatile Anesthetics as Sedatives for Acute Respiratory Distress Syndrome , 2019, Translational perioperative and pain medicine.

[38]  Zheng Zhang,et al.  High levels of circulating GM-CSF+CD4+ T cells are predictive of poor outcomes in sepsis patients: a prospective cohort study , 2018, Cellular & Molecular Immunology.

[39]  N. Leeper,et al.  Thrombotic Regulation From the Endothelial Cell Perspectives. , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[40]  A. Tsung,et al.  Neutrophil extracellular traps are indirectly triggered by lipopolysaccharide and contribute to acute lung injury , 2016, Scientific Reports.

[41]  Kelly R. Moran,et al.  A Meta-Analysis of the Association between Gender and Protective Behaviors in Response to Respiratory Epidemics and Pandemics , 2016, PloS one.

[42]  C. Bult,et al.  Temporal dynamics of the developing lung transcriptome in three common inbred strains of laboratory mice reveals multiple stages of postnatal alveolar development , 2016, PeerJ.

[43]  D. Farber,et al.  Airway CD8(+) T Cells Are Associated with Lung Injury during Infant Viral Respiratory Tract Infection. , 2016, American journal of respiratory cell and molecular biology.

[44]  John Ochsendorf.  Structure , 2015, Encyclopedia of Machine Learning and Data Mining.

[45]  B. Becher,et al.  The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity. , 2015, Immunity.

[46]  G. Whittaker,et al.  Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein , 2014, Proceedings of the National Academy of Sciences.

[47]  Jincun Zhao,et al.  T cell-mediated immune response to respiratory coronaviruses , 2014, Immunologic Research.

[48]  L. Burrell,et al.  Emerging markers in cardiovascular disease: Where does angiotensin‐converting enzyme 2 fit in? , 2013, Clinical and experimental pharmacology & physiology.

[49]  L. Eisenlohr,et al.  Perforin-dependent CD4+ T-cell cytotoxicity contributes to control a murine poxvirus infection , 2012, Proceedings of the National Academy of Sciences.

[50]  G. Whittaker,et al.  Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein , 2012, Viruses.

[51]  T. Tumpey,et al.  Human pulmonary microvascular endothelial cells support productive 1 replication of highly pathogenic avian influenza viruses : possible 2 involvement in the pathogenesis of human H 5 N 1 virus infection , 2011 .

[52]  W. V. van IJcken,et al.  Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human Primates , 2010, PLoS pathogens.

[53]  H. Wong,et al.  Leukocyte subset-derived genomewide expression profiles in pediatric septic shock* , 2009, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[54]  G. Whittaker,et al.  Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites , 2009, Proceedings of the National Academy of Sciences.

[55]  Kui Li,et al.  Severe Acute Respiratory Syndrome (SARS) Coronavirus-Induced Lung Epithelial Cytokines Exacerbate SARS Pathogenesis by Modulating Intrinsic Functions of Monocyte-Derived Macrophages and Dendritic Cells , 2008, Journal of Virology.

[56]  Arthur S Slutsky,et al.  Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. , 2008, American journal of physiology. Heart and circulatory physiology.

[57]  M. Daemen,et al.  Angiotensin‐converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions , 2008, The Journal of pathology.

[58]  Ralph Baric,et al.  A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice , 2007, PLoS pathogens.

[59]  Myriam Labalette,et al.  Accumulation of memory T cells from childhood to old age: Central and effector memory cells in CD4+ versus effector memory and terminally differentiated memory cells in CD8+ compartment , 2006, Mechanisms of Ageing and Development.

[60]  S. Perlman,et al.  ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway Epithelia , 2005, Journal of Virology.

[61]  Larissa B. Thackray,et al.  CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[62]  T. Greenough,et al.  What’s new in the renin-angiotensin system? , 2004, Cellular and Molecular Life Sciences CMLS.

[63]  A. Steinkasserer,et al.  DC-SIGN and DC-SIGNR Interact with the Glycoprotein of Marburg Virus and the S Protein of Severe Acute Respiratory Syndrome Coronavirus , 2004, Journal of Virology.

[64]  K. Subbarao,et al.  pH-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus Is Mediated by the Spike Glycoprotein and Enhanced by Dendritic Cell Transfer through DC-SIGN , 2004, Journal of Virology.

[65]  G. Navis,et al.  Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.

[66]  S. Shapiro,et al.  Neutrophil Elastase (NE)-Deficient Mice Demonstrate a Nonredundant Role for NE in Neutrophil Migration, Generation of Proinflammatory Mediators, and Phagocytosis in Response to Zymosan Particles In Vivo1 , 2004, The Journal of Immunology.

[67]  B. Bosch,et al.  The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex , 2003, Journal of Virology.

[68]  J. A. Comer,et al.  A novel coronavirus associated with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[69]  Richard I. Enelow,et al.  CD8+ T Cell–mediated Injury In Vivo Progresses in the Absence of Effector T Cells , 2001, The Journal of experimental medicine.

[70]  T. Takizawa,et al.  Virus Clearance through Apoptosis-Dependent Phagocytosis of Influenza A Virus-Infected Cells by Macrophages , 2000, Journal of Virology.

[71]  Runsheng Wang,et al.  A Retrospective Observational Study , 2020 .